Successful treatment of infantile refractory bullous pemphigoid with baricitinib

被引：1

作者：

Zhou, Weinan ^{[1
,2
,3
,4
]}

Tan, Yidong ^{[1
,2
,3
,4
]}

Chen, Xuanyi ^{[1
,2
,3
,4
]}

Zhang, Wenqing ^{[1
,2
,3
,4
]}

Sun, Zhe ^{[1
,2
,3
,4
]}

Shen, Yihang ^{[1
,2
,3
,4
]}

Yao, Zhirong ^{[1
,2
,3
,4
]}

Cheng, Ruhong ^{[1
,2
,3
,4
]}

Gu, Yan ^{[1
,2
,3
,4
]}

机构：

[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Dermatol Ctr, Sch Med, Shanghai, Peoples R China

[2] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Dermatol, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China

[3] Shanghai Jiao Tong Univ, Inst Dermatol, Sch Med, Shanghai, Peoples R China

[4] Shanghai Jiao Tong Univ, Xinhua Hosp, Dermatol Ctr, Dept Allergy,Sch Med, Shanghai, Peoples R China

来源：

AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2024年 / 65卷 / 08期

关键词：

baricitinib; bullous pemphigoid; infant; Janus kinase inhibitors; therapeutics;

D O I：

10.1111/ajd.14345

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Infantile bullous pemphigoid (BP) is a rare autoantibody-mediated skin disorder. We report the effective treatment of a 6-month-old infant with BP using baricitinib, a Janus kinase (JAK) inhibitor, after failure with steroids and intravenous immunoglobulin. The patient achieved full remission and discontinued all medications without any relapses. To our knowledge, this is the first case of baricitinib used in an infant with BP.

引用

页码：642 / 646

页数：5

共 10 条

[1] JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency [J].

Alsohime, Fahad ;

Martin-Fernandez, Marta ;

Temsah, Mohamad-Hani ;

Alabdulhafid, Majed ;

Le Voyer, Tom ;

Alghamdi, Malak ;

Qiu, Xueer ;

Alotaibi, Najla ;

Alkahtani, Areej ;

Buta, Sofija ;

Jouanguy, Emmanuelle ;

Al-Eyadhy, Ayman ;

Gruber, Conor ;

Hasan, Gamal M. ;

Bashiri, Fahad A. ;

Halwani, Rabih ;

Hassan, Hamdy H. ;

Al-Muhsen, Saleh ;

Alkhamis, Nouf ;

Alsum, Zobaida ;

Casanova, Jean-Laurent ;

Bustamante, Jacinta ;

Bogunovic, Dusan ;

Alangari, Abdullah A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (03) :256-265

[2] Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects [J].

Cozzani, Emanuele ;

Gasparini, Giulia ;

Burlando, Martina ;

Drago, Francesco ;

Parodi, Aurora .

AUTOIMMUNITY REVIEWS, 2015, 14 (05) :438-445

[3] The JAK/STAT signaling pathway: from bench to clinic [J].

Hu, Xiaoyi ;

Li, Jing ;

Fu, Maorong ;

Zhao, Xia ;

Wang, Wei .

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)

[4] A Comparison for Type 2 Cytokines and Lesional Inflammatory Infiltrations in Bullous Pemphigoid and Atopic Dermatitis [J].

Hu, Yu-qing ;

Zhang, Jian-zhong .

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 :2313-2321

[5] Incidence and Mortality of Bullous Pemphigoid in France [J].

Joly, Pascal ;

Baricault, Sophie ;

Sparsa, Agnes ;

Bernard, Philippe ;

Bedane, Christophe ;

Duvert-Lehembre, Sophie ;

Courville, Philippe ;

Bravard, Pierre ;

Remond, Brigitte ;

Doffoel-Hantz, Valerie ;

Benichou, Jacques .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (08) :1998-2004

[6] Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study [J].

Marazza, G. ;

Pham, H. C. ;

Schaerer, L. ;

Pedrazzetti, P. P. ;

Hunziker, T. ;

Trueeb, R. M. ;

Hohl, D. ;

Itin, P. ;

Lautenschlager, S. ;

Naldi, L. ;

Borradori, L. .

BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (04) :861-868

[7] Bullous pemphigoid in infants: characteristics, diagnosis and treatment [J].

Schwieger-Briel, Agnes ;

Moellmann, Cornelia ;

Mattulat, Birgit ;

Schauer, Franziska ;

Kiritsi, Dimitra ;

Schmidt, Enno ;

Sitaru, Cassian ;

Ott, Hagen ;

Kern, Johannes S. .

ORPHANET JOURNAL OF RARE DISEASES, 2014, 9 :185

[8]

Sousa Beatriz, 2005, Acta Med Port, V18, P159

[9]

Wechsler M, 2021, J ALLERGY CLIN IMMUN, V147, pAB140

[10] Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor Baricitinib [J].

Xiao, Yue ;

Xiang, Hongmei ;

Li, Wei .

DERMATOLOGIC THERAPY, 2022, 35 (10)

← 1 →